Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
Variants:
dbSNP: 285987
ClinVar: 285987
COSMIC: DLX6-AS1
Expression (GTEx)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 35093327 | 2022 | cAMP-response element binding protein mediates podocyte injury in diabetic nephropathy by targeting lncRNA DLX6-AS1. | 14 |
| 36017915 | 2022 | A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell. | 1 |
| 35093327 | 2022 | cAMP-response element binding protein mediates podocyte injury in diabetic nephropathy by targeting lncRNA DLX6-AS1. | 14 |
| 36017915 | 2022 | A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell. | 1 |
| 33035382 | 2021 | DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer. | 4 |
| 33277615 | 2021 | Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis. | 15 |
| 33550924 | 2021 | Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer. | 21 |
| 33607068 | 2021 | DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression. | 5 |
| 34514705 | 2021 | Silencing long non-coding RNA DLX6-AS1 or restoring microRNA-193b-3p enhances thyroid carcinoma cell autophagy and apoptosis via depressing HOXA1. | 7 |
| 34697393 | 2021 | DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis. | 9 |
| 34823630 | 2021 | DLX6-AS1: a putative lncRNA candidate in multiple human cancers. | 8 |
| 33035382 | 2021 | DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer. | 4 |
| 33277615 | 2021 | Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis. | 15 |
| 33550924 | 2021 | Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer. | 21 |
| 33607068 | 2021 | DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression. | 5 |
Citation
Dessen P
DLX6-AS1 (DLX6 antisense RNA 1)
Atlas Genet Cytogenet Oncol Haematol. 2019-04-01
Online version: http://atlasgeneticsoncology.org/gene/57841/dlx6-as1-(dlx6-antisense-rna-1)
